Credit: Thom Leach / Science Photo Library / Getty Images Approximately three million people worldwide struggle with chronic pancreatitis, for which there…
AstraZeneca has acquired exclusive global rights to develop and commercialize Dizal Pharmaceutical’s marketed lung cancer drug Zegfrovy® (sunvozertinib), through an…